Admission to Trading

In brief · summary, not quotable

Oxford Biomedica PLC has announced the admission of 40,801 ordinary shares to trading on the London Stock Exchange's Main Market, bringing the total number of shares in issue to 120,914,240. These new shares were allotted under the company's Long Term Incentive Plan, Sharesave Scheme, and Employee Share Option Scheme between March 4, 2026, and April 15, 2026, and are confirmed to be fungible with existing shares.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes

In accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, OXB notifies the market that following shares have been admitted to trading pursuant to their allotment under the OXB Long Term Incentive Plan (LTIP), OXB Sharesave Scheme (SAYE), OXB Employee Share Option Scheme (ESOS) as follows:

Issuer name:	OXFORD BIOMEDICA PLC
Issuer LEI:	213800S1GVQNXQ15K851
Name, type and ISIN of the shares:	Ordinary shares of 50p each GB00BDFBVT43
Number of further shares admitted to trading covered by the notification:	40,801
Total number of shares admitted to trading (including the new shares):	120,914,240
Date range covered by the notification:	04 March 2026 - 15 April 2026

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.